Indications |
Oral Darier's disease Adult: Initially, 10 mg daily for 2-4 wk. Max: 50 mg/day. Child: 500 mcg/kg/day. Max dose: 35 mg/day. Oral Congenital icthyosis Adult: Initially, 25-30 mg daily for 2-4 wk before dose adjustments are done. Usual range: 25-50 mg daily for further 6-8 wk. Max: 75 mg daily for short periods. Child: 500 mcg/kg/day. Max: 35 mg daily. Oral Severe psoriasis Adult: Initially, 25-30 mg daily for 2-4 wk before dose adjustments are done. Usual range: 25-50 mg daily for further 6-8 wk. Max: 75 mg daily for short periods. Child: 500 mcg/kg/day. Max: 35 mg daily. Oral Severe lichen planus Adult: Initially, 25-30 mg daily for 2-4 wk before dose adjustments are done. Usual range: 25-50 mg daily for further 6-8 wk. Max: 75 mg daily for short periods. Child: 500 mcg/kg/day. Max: 35 mg daily. |
Contraindications |
Pregnancy (before the start, during and at least 2-3 yr after cessation of therapy), lactation. Hepatic and renal impairment. Hyperlipidaemia. |
Warnings / Precautions |
Female patients to avoid alcohol during and 2 mth after treatment. Avoid blood donation during therapy or at least 1-3 yr after stopping therapy. Children. Radiographic treatment for prolonged therapy. Therapy should not last >6 mth. Monitor plasma lipid and glucose levels (especially diabetics) regularly. Monitor LFTs. |
Adverse Reactions |
Dryness of mucous membranes and skin; conjunctivitis, dry sore mouth; ophth disturbances; raised lipid level, pancreatitis; sticky skin, dermatitis. Severe headache; GI disturbances; dermatologic reactions, oedema, paronychia, granulomatous lesions, bullous eruptions; reversible hair thinning and alopoecia; CNS disturbances; sweating; taste disturbance, gingivitis; benign intracranial hypertension; photosensitivity; skeletal hyperostosis; extraosseous calcification; premature epiphyseal closure in child. Potentially Fatal: Phototoxicity, jaundice, hepatitis and hepatotoxity. |
Overdose Reactions |
Symptoms are identical to acute hypervitaminosis A, ie, headache and vertigo. |
Drug Interactions |
Concomitant use with keratolytics or high dose vitamin A. Reduces anticoagulant effect of coumarins e.g. warfarin. Concomitant use of microdised progestin oral contraceptives. Concomitant use of methotrexate can potentiate hepatotoxicty. Concomitant use with tetracycline. See Below for More acitretin Drug Interactions |
Lab Interactions |
Elevation of liver enzymes, lipids, triglycerides and cholesterol level in blood. |
Food Interactions |
Co-administration with food may increase oral bioavailability. |
Mechanism of Actions |
Acitretin is an active metabolite of etretinate but its mechanism of action is unknown. |
Administration |
Should be taken with food. (Take w/ main meals or w/ a glass of milk.) |
Storage Conditions |
Oral: Store below 25°C. |
ATC Classification |
D05BB02 - acitretin ; Belongs to the class of systemic retinoids used in the treatment of psoriasis. |
Storage |
Oral: Store below 25°C. |
Available As |
|
Acitretin
Post Review about Acitretin Click here to cancel reply.
Acitretin Containing Brands
Acitretin is used in following diseases
Drug - Drug Interactions of Acitretin
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.